The store will not work correctly when cookies are disabled.
Benzyl-(6,8-dimethyl-1H-pyrazolo[3',4':4,5]thieno[2,3-b]pyridin-3-yl)-amine
ID: ALA4558571
PubChem CID: 89445242
Max Phase: Preclinical
Molecular Formula: C17H16N4S
Molecular Weight: 308.41
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1cc(C)c2c(n1)sc1c(NCc3ccccc3)n[nH]c12
Standard InChI: InChI=1S/C17H16N4S/c1-10-8-11(2)19-17-13(10)14-15(22-17)16(21-20-14)18-9-12-6-4-3-5-7-12/h3-8H,9H2,1-2H3,(H2,18,20,21)
Standard InChI Key: OKALEASRBAPURD-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 25 0 0 0 0 0 0 0 0999 V2000
14.4975 -23.3848 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4964 -24.2044 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2044 -24.6133 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.2026 -22.9760 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2002 -22.1588 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9113 -23.3812 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9115 -24.2044 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6945 -24.4586 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
13.7884 -24.6124 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6941 -23.1267 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1832 -23.7935 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9685 -23.5344 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9648 -22.7074 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.1771 -22.4555 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.6318 -24.0117 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.3769 -23.6760 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0899 -24.0751 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0951 -24.8926 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8071 -25.2921 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.5106 -24.8745 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4975 -24.0531 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7850 -23.6574 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 7 2 0
6 4 2 0
4 1 1 0
4 5 1 0
6 7 1 0
7 8 1 0
8 11 1 0
10 6 1 0
2 9 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 10 1 0
12 15 1 0
15 16 1 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 308.41 | Molecular Weight (Monoisotopic): 308.1096 | AlogP: 4.40 | #Rotatable Bonds: 3 |
Polar Surface Area: 53.60 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 13.53 | CX Basic pKa: 2.83 | CX LogP: 3.86 | CX LogD: 3.86 |
Aromatic Rings: 4 | Heavy Atoms: 22 | QED Weighted: 0.59 | Np Likeness Score: -1.66 |
References
1. Poslusney MS, Salovich JM, Wood MR, Melancon BJ, Bollinger KA, Luscombe VB, Rodriguez AL, Engers DW, Bridges TM, Niswender CM, Conn PJ, Lindsley CW.. (2019) Novel M4 positive allosteric modulators derived from questioning the role and impact of a presumed intramolecular hydrogen-bonding motif in β-amino carboxamide-harboring ligands., 29 (3): [PMID:30580918] [10.1016/j.bmcl.2018.12.039] |